Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Scordo

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|September 21, 2022
Management of prolonged cytopenia following CAR T-cell therapyMagdalena Corona, Roni Shouval, Ana Alarcón, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2019
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple MyelomaAdam R Bryant, Patrick Hilden, Sergio Giralt, et al.
Bone Marrow Transplantation|January 31, 2023
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantationMiriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, et al.
Bone Marrow Transplantation|May 20, 2020
Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case seriesAlexandra Gomez-Arteaga, Michael Scordo, Roni Tamari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2020
Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood TransplantationVictoria Gutgarts, Insara Jaffer Sathick, Junting Zheng, et al.
Clinical Pharmacokinetics|December 3, 2021
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing RegimensGunjan L Shah, Jaap Jan Boelens, Dean Carlow, et al.
Cancers|June 13, 2025
Post-Transplant Pain and Paralysis: Neurologic Amyotrophy as an Atypical Cause of Shoulder Dysfunction Following Hematopoietic Stem Cell TransplantFranchesca König, Chanel Davidoff, Katarzyna Ibanez, et al.
British Journal of Haematology|March 6, 2020
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapyBrandon S Imber, Michel Sadelain, Carl DeSelm, et al.
Leukemia|May 23, 2019
Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphomaTania Jain, Craig S Sauter, Gunjan L Shah, et al.
Scientific Reports|March 2, 2021
Oncologic immunomodulatory agents in patients with cancer and COVID-19Justin Jee, Aaron J Stonestrom, Sean Devlin, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|September 21, 2022
Management of prolonged cytopenia following CAR T-cell therapyMagdalena Corona, Roni Shouval, Ana Alarcón, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2019
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple MyelomaAdam R Bryant, Patrick Hilden, Sergio Giralt, et al.
Bone Marrow Transplantation|January 31, 2023
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantationMiriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, et al.
Bone Marrow Transplantation|May 20, 2020
Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case seriesAlexandra Gomez-Arteaga, Michael Scordo, Roni Tamari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2020
Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood TransplantationVictoria Gutgarts, Insara Jaffer Sathick, Junting Zheng, et al.
Clinical Pharmacokinetics|December 3, 2021
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing RegimensGunjan L Shah, Jaap Jan Boelens, Dean Carlow, et al.
Cancers|June 13, 2025
Post-Transplant Pain and Paralysis: Neurologic Amyotrophy as an Atypical Cause of Shoulder Dysfunction Following Hematopoietic Stem Cell TransplantFranchesca König, Chanel Davidoff, Katarzyna Ibanez, et al.
British Journal of Haematology|March 6, 2020
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapyBrandon S Imber, Michel Sadelain, Carl DeSelm, et al.
Leukemia|May 23, 2019
Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphomaTania Jain, Craig S Sauter, Gunjan L Shah, et al.
Scientific Reports|March 2, 2021
Oncologic immunomodulatory agents in patients with cancer and COVID-19Justin Jee, Aaron J Stonestrom, Sean Devlin, et al.
Pageof 18